key: cord-0916346-84b1x5oi
authors: Raiker, Rahul; Pakhchanian, Haig; Pham, James; Phan, Kevin
title: Coronavirus disease 2019 complications in patients with hidradenitis suppurativa: A multicenter analysis
date: 2021-08-17
journal: J Dermatol
DOI: 10.1111/1346-8138.16073
sha: 4ce44fd6abea0bdbddc48df1a9a8b327e7ec8e58
doc_id: 916346
cord_uid: 84b1x5oi

nan

and obesity, as well as racial minorities, which may predispose to poor COVID-19 outcomes. 1 We aimed to investigate the effect of HS on COVID-19 complications to account for these comorbidities.

In this study, patients aged 18 years or more diagnosed with COVID-19 (between 20 January 2020 and 30 March 2021) were identified via real-time search and analysis of more than 68 million patients from 48 health-care organizations participating in TriNetX, a global federated database. Patients infected with COVID-19 (confirmed using criteria recommended by the World Health Organization) were divided into two groups based on the presence or absence of HS, identified via validated International Classification of Diseases, 10th

Revision (ICD-10) codes prior to the date of COVID-19 diagnosis.

The primary outcome was 30-day all-cause mortality post-COVID-19 diagnosis. Secondary outcomes were the need for mechanical ventilation, hospitalization, acute respiratory distress syndrome, sepsis, and severe COVID (composite of mortality and ventilation). There were no significant differences between COVID-19 patients with and without HS in any outcomes after matching (e.g., mortality aRR, 0.69 [95% CI, 0.6-1.8]; p = 1.00). Of the HS patients, 44% had a 1-year history of systemic antibiotic use and subgroup analyses revealed no significant differences in COVID-19 outcomes when compared to those without 1-year history of antibiotic use (Table 1) This finding supports the continued use of these medications to manage HS during the current pandemic and may alleviate concerns that their anti-inflammatory or immunosuppressive effects can confer worse COVID-19 outcomes.

None declared.

Rahul Raiker https://orcid.org/0000-0003-0636-3235

Kevin Phan https://orcid.org/0000-0002-5940-3555

Global Hidradenitis Suppurativa COVID-19 Registry: a registry to inform data-driven management practices

Impact of obesity on outcomes of patients with coronavirus disease 2019 in the United States. A multicenter electronic health records network study

COVID-19 in hidradenitis suppurativa -patients

Experience in patients with hidradenitis suppurativa and COVID-19 symptoms

Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors or methotrexate: a multicenter research network study